Cargando…
Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database Analysis
BACKGROUND: It is now a decade since the World Trade Organization (WTO) adopted the “Declaration on the TRIPS Agreement and Public Health” at its 4th Ministerial Conference in Doha. Many anticipated that these actions would lead nations to claim compulsory licenses (CLs) for pharmaceutical products...
Autores principales: | Beall, Reed, Kuhn, Randall |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254665/ https://www.ncbi.nlm.nih.gov/pubmed/22253577 http://dx.doi.org/10.1371/journal.pmed.1001154 |
Ejemplares similares
-
Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis
por: Son, Kyung-Bok
Publicado: (2019) -
Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
por: Ooms, Gorik, et al.
Publicado: (2014) -
TRIPS, the Doha Declaration and increasing access to medicines: policy options for Ghana
por: Cohen, JC, et al.
Publicado: (2005) -
The case for compulsory licensing during COVID-19
por: Wong, Hilary
Publicado: (2020) -
TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?
por: Kerry, Vanessa Bradford, et al.
Publicado: (2007)